Head of BreastCheck: ‘We are taking twice as long to do half the work at the moment’
Professor Ann O’Doherty, head of BreastCheck, defends the pausing of services during Covid-19 as she outlines the impact of two-metre physical distancing rules and points to the programme’s detection of over 12,200 cancers to date
Professor Ann O’Doherty is not one to pull her punches. When the CervicalCheck debacle unfolded, she was one of the few doctors who stood up to defend cancer screening programmes and tried to explain some home truths about the inherent limitations of the process, as well as the benefits and lives saved.
It is, presumably, for this reason that some of the HSE hierarchy are jittery when they hear the straight-talking head of...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
HSE never used Citywest conference centre as isolation hub despite multimillion refurbishment
Executive leased conference centre for use as an overspill facility but never used the conference centre despite millions being spent making it habitable
Róisin Shortall: Lack of political will is derailing Sláintecare’s health reforms
It’s not good enough to blame the pandemic for the slow pace of change in Irish healthcare, and the resignation last week of two key members of the Sláintecare programme was at least partly prompted by a lack of buy-in by politicians
HSE resistance to reform led to Sláintecare resignations
HSE and the Department of Health are opposing the plan to devolve powers to six regional health hubs
Elaine Byrne: Our conservative approach to medical cannabis is prolonging people’s suffering
The licensing of cannabis medication is overly bureaucratic, the products are expensive and reimbursement limited, so some individuals are risking prosecution by growing their own